PROPEL

Related by string. propel * * helped propel . Gatorade Propel . Gatorade Propel Fitness . Propel Invigorating Water . Propel PBM . NAWBO propels women . PROPEL trial . Samsung Propel . Propel Fuels . Propel Fitness Water . IR HUB propels . PROPEL Pralatrexate . Propel Pro . Propel Accelerator . Propel Biofuels . Half Propels . Propel Software . Propel Fit . Inning Propels . Helps Propel *

Related by context. Frequent words. (Click for all words.) 59 ZYBRESTAT 58 Phase 2a clinical 57 multicenter randomized double 57 dose escalation trial 57 phase IIb 57 Phase Ib 57 label dose escalation 56 Phase 2b 56 randomized Phase 56 dose escalation study 56 Phase 2b clinical 56 Phase IIb clinical 55 Phase 1b clinical 55 Phase 2a trial 55 phase 2a 55 Phase IIa trial 55 Phase 2b trial 55 Phase 2b study 55 Phase 1b 54 multicenter 54 pivotal Phase 54 Phase IIa clinical 53 pralatrexate 53 Phase 2a 53 Phase IIa 53 Phase IIb 53 pivotal Phase III 53 talactoferrin 53 multiple ascending dose 53 CoFactor 52 EORTC 52 Taxotere ® 52 HGS ETR1 52 DSMB 52 confirmatory Phase 3 52 Phase III pivotal 52 tolerated dose MTD 52 ofatumumab 52 AASLD 52 Phase III clinical 52 ADOPT 51 VALOR 51 sapacitabine 51 blind randomized placebo 51 BAY #-# 51 refractory multiple myeloma 51 randomized placebo controlled 51 IMGN# 51 ThermoDox 51 INFORM 50 ACTEMRA 50 Azixa 50 single ascending dose 50 AP# [003] 50 MGCD# [001] 50 clinical trial 50 Phase III 50 INSPIRE 50 REALIZE 50 Investigational Device Exemption IDE 50 Cotara 50 eculizumab 49 Phase IIb trial 49 belinostat 49 elagolix 49 randomized controlled 49 Phase III Trial 49 perifosine 49 FavId 49 T DM1 49 PEG Interferon lambda 49 HspE7 49 CRx 49 randomized double 49 eltrombopag 49 metastatic renal cell carcinoma 49 prospective randomized 49 ISA# [002] 49 dose escalation 49 CA4P 49 hepatocellular carcinoma HCC 49 blinatumomab 49 CYT# 48 HRPC 48 randomized clinical 48 FOLOTYN 48 castration resistant prostate cancer 48 voreloxin 48 MDV# 48 RDEA# 48 NGX# 48 Marqibo 48 Board DSMB 48 Phase II 48 unblinded 48 Completes Enrollment 48 ISENTRESS 48 Taxotere R 48 STELLAR 48 placebo controlled 48 GRN#L

Back to home page